News & Events category:
NIHR Manchester Biomedical Research Centre

A pioneering method of delivering research – popularised during the height of the COVID-19 pandemic – is being leveraged for the benefit of Greater Manchester residents.

Research finds interrupting the treatment of vulnerable people on long-term immune supressing medicines for two weeks after a COVID-19 booster vaccination doubles antibody response.

A new face mask designed by Manchester researchers is promising to end the stress and anxiety talkers and listeners experience when they cover up.

A leading MFT cancer professor MFT features in a documentary following TV presenter Julia Bradbury’s personal breast cancer journey.

A world-first genetic test, developed in Manchester, that could save the hearing of hundreds of babies each year has been successfully piloted in the NHS.

Three budding MFT entrepreneurs have been awarded places on the prestigious NHS Clinical Entrepreneur Programme.

The results of the world’s first Phase 3 trials, of a new drug Gefapixant, show that it can ease the often distressing symptoms of chronic cough, with minimal side effects.

The NIHR Immune Mediated Inflammatory Disease (IMID) BioResource recently hit a major recruitment milestone of 2000 volunteers, thanks to the collaborative effort of centres across England.